Sign Up to like & get
recommendations!
1
Published in 2023 at "Thoracic cancer"
DOI: 10.1111/1759-7714.14987
Abstract: BACKGROUND The discovery of immune checkpoint inhibitors (ICIs) is a breakthrough in the field of cancer therapy. However, ICIs may cause immune-related adverse reactions, including checkpoint inhibitor-related pneumonitis (CIP). The aim of this study was…
read more here.
Keywords:
checkpoint inhibitor;
bronchoalveolar lavage;
infection;
pulmonary infection ... See more keywords